Author details

Full Name

Charles W Boone

Affiliation

ORCID

Career Start Year

1953

Papers

195

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
17026078	Tissue self-affinity and polarized light scattering in the born approximation: a new model for precancer detection.	Physical Review Letters	2006
16292952	Prospective grading of neoplastic change in rat esophagus epithelium using angle-resolved low-coherence interferometry.	Journal of Biomedical Optics	2005
16254190	Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.	Molecular Cancer Research	2005
15177500	Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies.	European Journal of Cancer	2004
15501252	Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems.	Phytochemistry	2004
14992412	Spectroscopic diagnosis and imaging of invisible pre-cancer.		2004
12655525	Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma.	Cancer	2003
12839941	In situ detection of neoplastic transformation and chemopreventive effects in rat esophagus epithelium using angle-resolved low-coherence interferometry.	Cancer Research	2003
11916880	Cellular organization and substructure measured using angle-resolved low-coherence interferometry.	Biophysical Journal	2002
12234981	9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in Noble rats.	Cancer Research	2002
11830520	NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes.	Cancer Research	2002
12438244	Correlation between electron-donating ability of a series of 3-nitroflavones and their efficacy to inhibit the onset and progression of aberrant crypt foci in the rat colon.	Cancer Research	2002
11295594	Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.	Urology	2001
11457017	How curcumin works preferentially with water soluble antioxidants.	Journal of the American Chemical Society	2001
11303595	Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.	Cancer Epidemiol Biomarkers Prev	2001
11301476	Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.	Mol Carcinog	2001
11295610	Computer-assisted image analysis-derived intermediate endpoints.	Urology	2001
11097221	Chemoprevention with theaflavins of rat esophageal intraepithelial neoplasia quantitatively monitored by image tile analysis.	Cancer Epidemiology Biomarkers and Prevention	2000
10762017	Endpoint markers for cancer chemoprevention trials derived from the lesion of precancer (intraepithelial neoplasia) measured by computer-assisted quantitative image analysis.	Journal of cellular biochemistry. Supplement	2000
10698472	Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.	Cancer Epidemiol Biomarkers Prev	2000
11195462	Detection of genetic alterations in mouse lung adenocarcinomas by two-dimensional gel electrophoresis.	Experimental Lung Research	2000
10815694	Quantitative grading of rat esophageal carcinogenesis using computer-assisted image tile analysis.	Cancer Epidemiology Biomarkers and Prevention	2000
10607735	Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays.	Carcinogenesis	2000
10721931	Progress in cancer chemoprevention: development of diet-derived chemopreventive agents.	J Nutr	2000
10202390	Preclinical efficacy studies of green and black tea extracts.		1999
17283476	Can breast cancer be prevented?	Annals of Saudi Medicine	1999
10088542	Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.	Hum Pathol	1999
10516607	Nuclear morphometry as an intermediate endpoint biomarker in chemoprevention of cervical carcinoma using alpha-difluoromethylornithine.	Cytometry	1999
10325487	Chemoprevention of prostate cancer: concepts and strategies.	European Urology	1999
10613341	Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials.	Cancer Epidemiol Biomarkers Prev	1999
10668477	Progress in cancer chemoprevention.	Ann N Y Acad Sci	1999
10489626	Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.	Cancer Surveys	1998
9858893	Protective action of plant polyphenols on radiation-induced chromatid breaks in cultured human cells.	Anticancer Research	1998
9456245	Aromatase inhibitors as potential cancer chemopreventives.	Cancer Epidemiol Biomarkers Prev	1998
9650918	Workgroup 3: transgenic and reconstitution models of prostate cancer.	Prostate	1998
9421213	Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancer.		1998
9888015	Preclinical drug development paradigms for chemopreventives.	Hematology/Oncology Clinics of North America	1998
9886568	Oltipraz, a novel inhibitor of hepatitis B virus transcription through elevation of p53 protein.	Carcinogenesis	1998
9675271	Use of Druckrey analysis to quantitatively evaluate the chemopreventive efficacy of N-difluoromethylornithine (DFMO), a prototype proliferation inhibitor.	Mutation Research	1998
9474054	Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoring.	Clin Chem	1998
9349684	Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials.		1997
9129692	Progress in clinical chemoprevention.	Semin Oncol	1997
9332769	DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasia.	Cancer Epidemiology Biomarkers and Prevention	1997
9589347	Quantitation of preinvasive neoplastic progression in animal models of chemical carcinogenesis.	Journal of cellular biochemistry. Supplement	1997
9589346	Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents.	Journal of cellular biochemistry. Supplement	1997
9383778	Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis.	Nutrition and Cancer	1997
9108597	Perspectives and progress in development of breast cancer chemopreventive drugs.	Prog Clin Biol Res	1997
9107432	Farnesyl protein transferase inhibitors as potential cancer chemopreventives.	Cancer Epidemiology Biomarkers and Prevention	1997
9354926	Biomarker end-points in cancer chemoprevention trials.	IARC scientific publications	1997
8824370	Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.	Cancer Epidemiology Biomarkers and Prevention	1996

1 - 50 of 195

Ernest T Hawk

The University of Texas MD Anderson Cancer Center

Co-authored papers 14

Mitchell H Gail

Co-authored papers 9

Levy Kopelovich

Co-authored papers 3

Scott M Lippman

Moores Cancer Center, university of california san diego

Co-authored papers 3

Susan R Davis

Co-authored papers 3

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 3

Carol L Sabourin

Battelle Memorial Institute

Co-authored papers 2

Stephen J O'Brien

Co-authored papers 2

Christopher P Crum

Co-authored papers 2

Barbara L Weber

Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania

Co-authored papers 1

Laurent Vergnes